+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Multiplex Assays Market by Product & Service, Type, Technology, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674086
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Multiplex Assays Market grew from USD 3.89 billion in 2023 to USD 4.21 billion in 2024. It is expected to continue growing at a CAGR of 8.50%, reaching USD 6.88 billion by 2030.

Multiplex assays are advanced analytical tools enabling simultaneous measurement of multiple analytes in a single assay. Their scope spans across various fields such as clinical diagnostics, pharmaceutical drug discovery, and academic research, driven by the necessity for enhanced throughput, reduced costs, and more comprehensive data acquisitions. In clinical settings, multiplex assays facilitate biomarker detection, expediting diagnostics and personalized medicine. The pharmaceutical industry leverages these assays for high-throughput screening, lead identification, and validation in drug development processes. Recent market insights suggest that growing demand for personalized therapies, particularly in oncology, coupled with advancements in genomics and proteomics, are significant growth drivers. This expanding demand, notably in North America and Asia-Pacific regions, presents potential opportunities, particularly with the increasing interest in precision medicine and companion diagnostics. Recommendations to capitalize on these opportunities include product diversification, incorporation of novel technologies like microfluidics and artificial intelligence to enhance assay sensitivity and efficiency, and strategic partnerships or collaborations to expand market reach.

Nevertheless, the market does face limitations and challenges, including high costs associated with test development, complexity in data interpretation, and strict regulatory requirements that often prolong product time-to-market. Additionally, the skill gap in handling complex technologies and integration issues with existing laboratory infrastructure may hinder swift adoption. To overcome these hurdles and stimulate business growth, innovation should focus on developing cost-effective, user-friendly multiplex platforms that integrate smoothly with current laboratory workflows. Enhanced automation and miniaturization, combined with improved data analysis tools, can significantly reduce operational challenges, thus broadening the customer base. The nature of the multiplex assays market is highly competitive, with continuous research and innovation imperative for maintaining competitive positioning. Businesses should focus on research areas such as biomarker discovery, development of novel assay formats, and expansion into emerging markets to sustain growth and capture new market opportunities.

Understanding Market Dynamics in the Multiplex Assays Market

The Multiplex Assays Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising chronic and infectious disease and rapid shift towards early diagnosis
    • Surge in usage of personalized-precision medications
    • Growing application of multiple assays in drug development
  • Market Restraints
    • Associated shear complexity of multiplex assays and high cost of instruments
  • Market Opportunities
    • Emerging technology of multiplexing in clinical diagnostics
    • Potential adoption of automated instruments and equipment in clinical practice
  • Market Challenges
    • Shortage of skilled and experienced healthcare professionals

Exploring Porter’s Five Forces for the Multiplex Assays Market

Porter’s Five Forces framework further strengthens the insights of the Multiplex Assays Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Multiplex Assays Market

External macro-environmental factors deeply influence the performance of the Multiplex Assays Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Multiplex Assays Market

The Multiplex Assays Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Multiplex Assays Market

The Multiplex Assays Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Multiplex Assays Market

The Multiplex Assays Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiplex Assays Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Antigenix America, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cayman Chemical Company, Charles River Laboratories, Enfer Group, Enzo Life Sciences, Inc., Eve Technologies Corp., Flagship Biosciences Inc., Future Diagnostics Solutions B.V., Gnome Diagnostics and Gnome Sciences, Illumina, Inc., Merck KGaA, MESO SCALE DIAGNOSTICS, LLC, Novatein Biosciences Inc., PerkinElmer, Inc., Protavio Ltd., Siemens Healthineers AG, Solis BioDyne OÜ, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiplex Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product & Service
    • Consumables
    • Instruments
    • Software & Services
  • Type
    • Cell-Based Multiplex Assays
    • Nucleic Acid Multiplex Assays
      • Bead-Based Nucleic Acid Assays
      • Planar Nucleic Acid Assays
    • Protein Multiplex Assays
      • Bead-Based Protein Assays
      • Planar Protein Assays
  • Technology
    • Flow Cytometry
    • Fluorescence Detection
    • Luminescence
    • Multiplex Real-Time Flow Cytometry
    • Multiplex Real-Time PCR
  • Application
    • Clinical Diagnostics
      • Autoimmune Diseases
      • Cancer
      • Cardiovascular Diseases
      • Infectious Diseases
      • Metabolism & Endocrinology Disorders
      • Nervous System Disorders
    • Research & Development
      • Biomarker Discovery & Validation
      • Drug Discovery & Development
  • End User
    • Hospitals & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Reference Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising chronic and infectious disease and rapid shift towards early diagnosis
5.1.1.2. Surge in usage of personalized-precision medications
5.1.1.3. Growing application of multiple assays in drug development
5.1.2. Restraints
5.1.2.1. Associated shear complexity of multiplex assays and high cost of instruments
5.1.3. Opportunities
5.1.3.1. Emerging technology of multiplexing in clinical diagnostics
5.1.3.2. Potential adoption of automated instruments and equipment in clinical practice
5.1.4. Challenges
5.1.4.1. Shortage of skilled and experienced healthcare professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Multiplex Assays Market, by Product & Service
6.1. Introduction
6.2. Consumables
6.3. Instruments
6.4. Software & Services
7. Multiplex Assays Market, by Type
7.1. Introduction
7.2. Cell-Based Multiplex Assays
7.3. Nucleic Acid Multiplex Assays
7.3.1. Bead-Based Nucleic Acid Assays
7.3.2. Planar Nucleic Acid Assays
7.4. Protein Multiplex Assays
7.4.1. Bead-Based Protein Assays
7.4.2. Planar Protein Assays
8. Multiplex Assays Market, by Technology
8.1. Introduction
8.2. Flow Cytometry
8.3. Fluorescence Detection
8.4. Luminescence
8.5. Multiplex Real-Time Flow Cytometry
8.6. Multiplex Real-Time PCR
9. Multiplex Assays Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.2.1. Autoimmune Diseases
9.2.2. Cancer
9.2.3. Cardiovascular Diseases
9.2.4. Infectious Diseases
9.2.5. Metabolism & Endocrinology Disorders
9.2.6. Nervous System Disorders
9.3. Research & Development
9.3.1. Biomarker Discovery & Validation
9.3.2. Drug Discovery & Development
10. Multiplex Assays Market, by End User
10.1. Introduction
10.2. Hospitals & Research Institutes
10.3. Pharmaceutical & Biotechnology Companies
10.4. Reference Laboratories
11. Americas Multiplex Assays Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Multiplex Assays Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Multiplex Assays Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. MULTIPLEX ASSAYS MARKET RESEARCH PROCESS
FIGURE 2. MULTIPLEX ASSAYS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. MULTIPLEX ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. MULTIPLEX ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. MULTIPLEX ASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. MULTIPLEX ASSAYS MARKET DYNAMICS
TABLE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEAD-BASED NUCLEIC ACID ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PLANAR NUCLEIC ACID ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEAD-BASED PROTEIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PLANAR PROTEIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY LUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MULTIPLEX REAL-TIME FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MULTIPLEX REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY METABOLISM & ENDOCRINOLOGY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 73. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 75. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 76. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 79. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 80. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 89. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 120. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 122. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 123. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 126. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 127. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 129. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 131. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 132. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 135. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 136. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 147. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 149. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 150. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 153. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 154. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 201. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 203. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 204. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 207. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 208. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 228. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 229. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 231. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 232. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 235. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 236. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 238. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 240. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 241. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 244. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 245. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 247. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 249. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 250. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 253. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 254. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 256. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 258. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 259. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 262. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 263. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 265. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 267. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 268. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 271. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 272. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 283. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 285. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 286. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 289. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 290. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 301. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 310. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 311. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 312. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 313. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 316. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 317. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 319. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 320. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 321. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 322. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 325. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 326. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 328. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 329. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 330. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 331. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 332. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 333. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 334. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 335. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 337. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 338. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 339. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
TABLE 340. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 341. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 343. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 201

Companies Mentioned

The leading players in the Multiplex Assays Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Abcam PLC
  • Agilent Technologies, Inc.
  • Antigenix America, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cayman Chemical Company
  • Charles River Laboratories
  • Enfer Group
  • Enzo Life Sciences, Inc.
  • Eve Technologies Corp.
  • Flagship Biosciences Inc.
  • Future Diagnostics Solutions B.V.
  • Gnome Diagnostics and Gnome Sciences
  • Illumina, Inc.
  • Merck KGaA
  • MESO SCALE DIAGNOSTICS, LLC
  • Novatein Biosciences Inc.
  • PerkinElmer, Inc.
  • Protavio Ltd.
  • Siemens Healthineers AG
  • Solis BioDyne OÜ
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information